QUANTIPLEX Trademark

Trademark Overview


On Wednesday, December 12, 2012, a trademark application was filed for QUANTIPLEX with the United States Patent and Trademark Office. The USPTO has given the QUANTIPLEX trademark a serial number of 79124568. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Saturday, June 1, 2024. This trademark is owned by QIAGEN GmbH. The QUANTIPLEX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

[ Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); chemical, biochemical and biotechnological preparations, namely, reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic medical and clinical use, namel...

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, [ diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical ] reagents, enzymes and buffer solutions for [ scientific and medical research use for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for ] nucleic acid amplification by polymerase chain reaction (PCR) [ ; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids of biological or biochemical sample material comprising...
quantiplex

General Information


Serial Number79124568
Word MarkQUANTIPLEX
Filing DateWednesday, December 12, 2012
Status706 - SECTION 71 ACCEPTED
Status DateSaturday, June 1, 2024
Registration Number4405272
Registration DateTuesday, September 24, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2013

Trademark Statements


Goods and Services[ Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); chemical, biochemical and biotechnological preparations, namely, reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic medical and clinical use, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); ] kits containing [ preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids from biological or ] biochemical sample material for nucleic acid amplification by polymerase chain reaction (PCR)
Goods and ServicesChemical, biochemical and biotechnological products for industrial and scientific purposes, namely, [ diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical ] reagents, enzymes and buffer solutions for [ scientific and medical research use for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for ] nucleic acid amplification by polymerase chain reaction (PCR) [ ; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids of biological or biochemical sample material comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR) ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, February 11, 2013
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 11, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQIAGEN GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHilden 40724
DE

Party NameQIAGEN GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE

Party NameQIAGEN GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events


Event DateEvent Description
Friday, March 15, 2013ASSIGNED TO EXAMINER
Saturday, February 9, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 15, 2013APPLICATION FILING RECEIPT MAILED
Friday, March 22, 2013NON-FINAL ACTION WRITTEN
Saturday, March 23, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 25, 2013REFUSAL PROCESSED BY MPU
Monday, March 25, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 16, 2013REFUSAL PROCESSED BY IB
Friday, May 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 31, 2013ASSIGNED TO LIE
Monday, June 3, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 19, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 19, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 19, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 9, 2013PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 22, 2013NOTIFICATION PROCESSED BY IB
Tuesday, September 24, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, January 9, 2014FINAL DISPOSITION PROCESSED
Thursday, January 9, 2014FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 25, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 22, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 29, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 24, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, October 18, 2018NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, July 31, 2019TEAS SECTION 71 & 15 RECEIVED
Monday, August 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 27, 2019REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, August 27, 2019NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, September 24, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, December 30, 2022INTERNATIONAL REGISTRATION RENEWED
Tuesday, September 5, 2023TEAS SECTION 71 RECEIVED
Sunday, May 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 13, 2024POST REGISTRATION ACTION MAILED - SEC.71
Tuesday, May 28, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, June 1, 2024REGISTERED-SEC.71 ACCEPTED
Saturday, June 1, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED